Stay updated with breaking news from Nasdaq Nmrd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nemaura Medical (NASDAQ:NMRD – Free Report) had its price objective trimmed by HC Wainwright from $7.00 to $2.50 in a research report report published on Monday morning, Marketbeat Ratings reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for Nemaura Medical’s Q1 2025 earnings at ($0.08) EPS, Q2 […]
Loughborough, England, July 14, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company...
Nemaura Medical Inc. (NASDAQ:NMRD – Get Rating)’s share price traded down 4.4% on Thursday . The company traded as low as $0.65 and last traded at $0.65. 6,398 shares changed hands during mid-day trading, a decline of 94% from the average session volume of 116,042 shares. The stock had previously closed at $0.68. Wall Street […]
Nemaura Medical (NASDAQ:NMRD – Get Rating) and Sintx Technologies (NASDAQ:SINT – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings and analyst recommendations. Profitability This table compares Nemaura Medical and Sintx Technologies’ […]
EF Hutton Acquisition Co. I restated their buy rating on shares of Nemaura Medical (NASDAQ:NMRD – Get Rating) in a research note published on Thursday morning, Benzinga reports. The firm currently has a $6.00 target price on the stock. Separately, HC Wainwright cut their price objective on shares of Nemaura Medical from $8.00 to $7.00 […]